Who is sponsoring NCT05107089?

NCT05107089 is sponsored by Assiut University.

What drugs are being tested in NCT05107089?

Interventions in NCT05107089: Ultrasound.

What condition does NCT05107089 study?

NCT05107089 studies Ultrasound Subclavian Cannulation.

Is NCT05107089 still recruiting?

NCT05107089 is currently status unknown. Last updated 4 November 2021.

Last reviewed 2021-11-04 · How we verify

NCT05107089

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ultrasound Guided Subclavian Vein Cannulation at Emergency Room

Status unknown Last updated 4 November 2021

What this trial tests

trial testing Ultrasound in Ultrasound Subclavian Cannulation in 30 participants. Status unknown.

Timeline

1 November 2021

Primary endpoint
1 November 2024

1 March 2025

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 November 2021
Primary completion	1 November 2024
Estimated completion	1 March 2025

Drugs / interventions tested

Ultrasound

Conditions studied

Ultrasound Subclavian Cannulation — all drugs for Ultrasound Subclavian Cannulation →

Sponsor

Assiut University

Who can join

Adults 18 to 80, any sex, with Ultrasound Subclavian Cannulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. To observe and report the success rate associated with the use of ultrasound for subclavian vein catheterization. 2. To observe and report the type and complications and any constrains associated with this technique.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ultrasound

Trials testing the same drug.

NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
NCT07505433 — Ultrasound Monitoring of Bone Healing in Ilizarov Bone Transport · not yet recruiting
NCT07498517 — Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT · Phase 2 · not yet recruiting
NCT07342790 — Artificial Intelligence Clinical Decision · NA · not yet recruiting
NCT07169890 — Clinical Insights Into Dextrose Phonophoresis on Mild to Moderate Acne Vulgaris · NA · completed

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05107089 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 4 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05107089.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing